RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 44.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+44.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$904M
AUM Growth
+$113M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1
+$14.7M
2
+$12.4M
3
+$9.71M
4
AXSM icon
Axsome Therapeutics
AXSM
+$9.24M
5
PRCT icon
Procept Biorobotics
PRCT
+$9.13M

Top Sells

1
+$13.9M
2
+$13.8M
3
+$11.4M
4
VRNA
Verona Pharma
VRNA
+$10.1M
5
GILD icon
Gilead Sciences
GILD
+$10M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
26
Cytokinetics
CYTK
$7.85B
$14M 1.55%
255,250
+151,000
PRCT icon
27
Procept Biorobotics
PRCT
$1.36B
$13.9M 1.54%
390,000
+200,000
CI icon
28
Cigna
CI
$69.2B
$13.4M 1.48%
46,500
+14,500
ABT icon
29
Abbott
ABT
$192B
$13.2M 1.46%
98,500
+40,000
JAZZ icon
30
Jazz Pharmaceuticals
JAZZ
$11.4B
$12.5M 1.39%
95,030
-14,000
EW icon
31
Edwards Lifesciences
EW
$49.8B
$12.1M 1.33%
155,000
+100,000
THC icon
32
Tenet Healthcare
THC
$20.6B
$11.9M 1.31%
58,429
-78,000
AKRO
33
DELISTED
Akero Therapeutics
AKRO
$10.9M 1.21%
230,600
+33,000
ALGN icon
34
Align Technology
ALGN
$12.1B
$10.4M 1.15%
83,000
+16,500
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.7B
$10.1M 1.12%
186,650
+37,000
DOCS icon
36
Doximity
DOCS
$4.58B
$9.95M 1.1%
136,000
+115,000
RPRX icon
37
Royalty Pharma
RPRX
$19.7B
$9.12M 1.01%
258,500
-85,500
GILD icon
38
Gilead Sciences
GILD
$184B
$8.9M 0.98%
80,150
-88,000
SNDX icon
39
Syndax Pharmaceuticals
SNDX
$2.13B
$8.83M 0.98%
574,000
MDGL icon
40
Madrigal Pharmaceuticals
MDGL
$9.83B
$8.37M 0.93%
+18,250
BIIB icon
41
Biogen
BIIB
$27.7B
$7.7M 0.85%
55,000
+43,000
DVAX
42
DELISTED
Dynavax Technologies
DVAX
$7.67M 0.85%
772,000
+207,000
ADPT icon
43
Adaptive Biotechnologies
ADPT
$2.24B
$7.41M 0.82%
+495,000
ELV icon
44
Elevance Health
ELV
$62.4B
$7.27M 0.8%
22,500
-22,150
DNTH icon
45
Dianthus Therapeutics
DNTH
$3.76B
$6.83M 0.76%
173,627
+47,000
MLYS icon
46
Mineralys Therapeutics
MLYS
$2.25B
$6.26M 0.69%
+165,000
CNC icon
47
Centene
CNC
$17.9B
$6.07M 0.67%
170,000
+70,243
STOK icon
48
Stoke Therapeutics
STOK
$2.19B
$5.88M 0.65%
+250,000
VKTX icon
49
Viking Therapeutics
VKTX
$4.01B
$5.68M 0.63%
216,288
+131,288
AVR
50
Anteris Technologies
AVR
$620M
$5.63M 0.62%
1,250,763
1
2
3 4 5